InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Toy Andrew, Chief Executive Officer. Insider active across 1 companies, notably Clover Health Investments, CORP. /de. Cumulatively, 14 disclosures have been logged. The latest transaction was disclosed on 8 May 2026 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Declarations14 total
US$206,01385,704 shares@ US$2.40380.017% mcap8.5% of flow
Class A Common Stock
SEC:0001801170-26-000123·
€206,01385,704 shares@ €2.40380.017% mcap4.3% of flow
Class A Common Stock
SEC:0001801170-26-000123:0·
US$104,97060,765 shares@ US$1.72750.0086% mcap4.3% of flow
Class A Common Stock
SEC:0001838733-26-000012·
€104,97060,765 shares@ €1.72750.0086% mcap2.2% of flow
Class A Common Stock
SEC:0001838733-26-000012:0·
US$154,99485,704 shares@ US$1.80850.013% mcap6.4% of flow
Class A Common Stock
SEC:0001838733-26-000007·
€154,99485,704 shares@ €1.80850.013% mcap3.2% of flow
Class A Common Stock
SEC:0001838733-26-000007:0·
US$146,61060,764 shares@ US$2.41280.012% mcap6.1% of flow
Class A Common Stock
SEC:0001801170-26-000028·
€146,61060,764 shares@ €2.41280.012% mcap3.0% of flow
Class A Common Stock
SEC:0001801170-26-000028:0·
US$536,040267,958 shares@ US$2.00050.044% mcap22.1% of flow
Class A Common Stock
SEC:0001838733-26-000003·
€536,040267,958 shares@ €2.00050.044% mcap11.1% of flow
Class A Common Stock
SEC:0001838733-26-000003:0·
US$583,209242,580 shares@ US$2.40420.048% mcap24.1% of flow
Class A Common Stock
SEC:0001838733-25-000008·
€583,209242,580 shares@ €2.40420.048% mcap12.0% of flow
Class A Common Stock
SEC:0001838733-25-000008:0·
US$689,829308,950 shares@ US$2.23280.057% mcap28.5% of flow
Class A Common Stock
SEC:0001801170-25-000239·
€689,829308,950 shares@ €2.23280.057% mcap14.2% of flow
Class A Common Stock
SEC:0001801170-25-000239:0·
14 of 14 declarations
About Toy Andrew
Andrew Toy is the Chief Executive Officer of CLOVER HEALTH INVESTMENTS, CORP. /DE. He leads the company's operations, focusing on enhancing healthcare services and innovation. His leadership is essential for achieving growth and development objectives.
